Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.649, 2012-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Dilemma of New Drugs: Are Costs Rising Faster than Effectiveness?
PharmacoEconomics, Vol. 13, Iss. 6, 1998-06 ,pp. :
Access to resources
Recommend
The pros and cons of Rx-to-OTC switching of drugs in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
The pros and cons of Rx-to-OTC switching of drugs in the US
Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. :
Affordability of Rx drugs similar in Canada and the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 635, 2011-01 ,pp. :
Clamp down on Rx drugs without US FDA approval
Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. :